Mesoblast (MESO) News Today $13.30 -0.55 (-3.97%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$13.38 +0.07 (+0.56%) As of 03/27/2025 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period 2 ASX 200 biotech stocks announcing big news todayMarch 28 at 1:52 AM | msn.comRyoncil® is Now Available for Purchase in the United StatesMarch 26 at 8:19 PM | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Up - What's Next?Mesoblast (NASDAQ:MESO) Shares Gap Up - Still a Buy?March 21, 2025 | marketbeat.comA chronographic analysis of MSC's rollercoasting journeyMarch 18, 2025 | finance.yahoo.comRyoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United StatesMarch 13, 2025 | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - What's Next?March 12, 2025 | marketbeat.comMesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town HallMarch 12, 2025 | globenewswire.comMesoblast Limited (MESO): Among the Best Australian Stocks to Buy According to BillionairesMarch 10, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Down 5.7% - What's Next?Mesoblast (NASDAQ:MESO) Trading Down 5.7% - Here's WhyMarch 7, 2025 | marketbeat.comMesoblast Added to S&P/ASX 200 INDEXMarch 7, 2025 | markets.businessinsider.comCantor Fitzgerald Predicts Mesoblast FY2025 EarningsMesoblast Limited (NASDAQ:MESO - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Mesoblast in a research report issued to clients and investors on Tuesday, March 4th. Cantor Fitzgerald analyst K. Kluska anticipates that the company will post earnings per share oMarch 7, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Rating Increased to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald upgraded Mesoblast to a "strong-buy" rating in a research report on Tuesday.March 6, 2025 | marketbeat.comAPRA targets boards; Cyclone Alfred intensifies; Trump’s chain reactionMarch 6, 2025 | afr.comWhy Appen, Mesoblast, Rio Tinto, and Woodside shares are falling todayMarch 6, 2025 | msn.comListen: HotCopper Podcast 004 – Trump gets his trade war, Mesoblast losing steamMarch 5, 2025 | msn.comJefferies Keeps Their Hold Rating on Mesoblast Limited (MEOBF)March 3, 2025 | markets.businessinsider.comMesoblast Limited (NASDAQ:MESO) Q2 2025 Earnings Call TranscriptMarch 3, 2025 | msn.comUp 810% in a year, the Mesoblast share price is surging again on Monday. Here's whyMarch 2, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Up - Time to Buy?Mesoblast (NASDAQ:MESO) Shares Gap Up - Still a Buy?March 1, 2025 | marketbeat.comMesoblast Limited (MESO) Q2 2025 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comMesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This QuarterFebruary 26, 2025 | globenewswire.comMesoblast Financial Results and Corporate Update WebcastFebruary 25, 2025 | globenewswire.comDr. Gregory George MD PhD Joins Mesoblast BoardFebruary 23, 2025 | globenewswire.comMesoblast (MESO) Projected to Post Earnings on ThursdayMesoblast (NASDAQ:MESO) will be releasing earnings on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=492137)February 20, 2025 | marketbeat.comStrategic Financial Concepts LLC Buys Shares of 138,600 Mesoblast Limited (NASDAQ:MESO)Strategic Financial Concepts LLC bought a new stake in Mesoblast Limited (NASDAQ:MESO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 138,600 shares of the company's stock, valued at approximaFebruary 18, 2025 | marketbeat.comMesoblast: Ryoncil Approval Overshadowed By Commercial HurdlesFebruary 15, 2025 | seekingalpha.comMesoblast Limited: Ryoncil FDA Approval and Market Launch Highlighted at Tandem Transplantation MeetingsFebruary 14, 2025 | finanznachrichten.deRyoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation MeetingsFebruary 13, 2025 | globenewswire.comDomino's Pizza Enterprises And 2 Other ASX Stocks That Might Be Trading Below Fair ValueFebruary 12, 2025 | finance.yahoo.comASX companies waiting for US FDA kick-offFebruary 11, 2025 | msn.comIs Mesoblast Limited (MESO) the Best Long Term ASX Stock to Buy Now?February 11, 2025 | msn.comStrategic Financial Concepts LLC Invests $2.74 Million in Mesoblast Limited (NASDAQ:MESO)Strategic Financial Concepts LLC purchased a new stake in Mesoblast Limited (NASDAQ:MESO - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 138,600 shares of the company's stock, valFebruary 10, 2025 | marketbeat.comPiper Sandler Remains a Buy on Mesoblast (MESO)February 8, 2025 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Receives "Overweight" Rating from Piper SandlerPiper Sandler reaffirmed an "overweight" rating and set a $24.00 price objective (up from $15.00) on shares of Mesoblast in a report on Friday.February 7, 2025 | marketbeat.comWhy Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling todayFebruary 5, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?February 5, 2025 | marketbeat.comClayton Financial Group LLC Buys Shares of 13,893 Mesoblast Limited (NASDAQ:MESO)Clayton Financial Group LLC bought a new position in Mesoblast Limited (NASDAQ:MESO - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 13,893 shares of the company's stock, valued at approximaFebruary 5, 2025 | marketbeat.comDr Boreham’s Crucible: FDA approval blasted this regenerative biotech higher in 2024… so what’s next?February 3, 2025 | msn.comMesoblast (NASDAQ:MESO) Upgraded to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald raised Mesoblast to a "strong-buy" rating in a report on Thursday.February 1, 2025 | marketbeat.comIs Mesoblast Limited (MESO) One of the Best ASX Stocks to Buy According to Hedge Funds?February 1, 2025 | msn.comChronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the DomainJanuary 30, 2025 | finance.yahoo.comMesoblast provides update on progress of U.S. commercial launch of RyoncilJanuary 30, 2025 | markets.businessinsider.comUp 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?January 30, 2025 | msn.comRyoncil® Commercial Launch Update and Product PipelineJanuary 30, 2025 | globenewswire.comAppendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024January 30, 2025 | globenewswire.com$1,000 invested in Mesoblast shares at the start of 2024 is now worth…January 30, 2025 | msn.comMesoblast Limited (NASDAQ:MESO) Holdings Decreased by Penbrook Management LLCPenbrook Management LLC trimmed its position in Mesoblast Limited (NASDAQ:MESO - Free Report) by 15.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 91,075 shares of the company's stock after selling 16,200 shares during tJanuary 30, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Trading Up 4.8% - Here's WhyMesoblast (NASDAQ:MESO) Trading Up 4.8% - Time to Buy?January 29, 2025 | marketbeat.comWhy Mesoblast (MESO) Is Among the Best Australian Stocks to Buy Now?January 27, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Down - Here's WhyMesoblast (NASDAQ:MESO) Shares Gap Down - Here's What HappenedJanuary 24, 2025 | marketbeat.com Remove Ads Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address MESO Media Mentions By Week MESO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MESO News Sentiment▼1.020.79▲Average Medical News Sentiment MESO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MESO Articles This Week▼44▲MESO Articles Average Week Remove Ads Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BBIO News Today LNTH News Today TGTX News Today LEGN News Today AXSM News Today TLX News Today BPMC News Today KRYS News Today NUVL News Today CYTK News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MESO) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MESO Stock Free MESO Stock Alerts